Original Research
Published on 02 Feb 2024
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
in Vaccines and Molecular Therapeutics
- 2,767 views
- 5 citations